"Melanoma cells expressing mutant GRM3 had reduced cell growth and cellular migration after short hairpin RNA-mediated knockdown of GRM3 or treatment with a selective MEK inhibitor AZD-6244 which is currently being used in phase 2 clinical trials"xsd:string